Personal tools

MCL coexpression mm9:3631: Difference between revisions

From FANTOM5_SSTAR

Jump to: navigation, search
No edit summary
No edit summary
Line 6: Line 6:
|ontology_enrichment_disease=
|ontology_enrichment_disease=
|ontology_enrichment_uberon=UBERON:0010314!8.87e-25!92;UBERON:0000073!8.70e-22!54;UBERON:0001049!2.12e-20!52;UBERON:0005068!2.12e-20!52;UBERON:0006241!2.12e-20!52;UBERON:0007135!2.12e-20!52;UBERON:0002346!4.36e-20!64;UBERON:0003075!4.36e-20!64;UBERON:0007284!4.36e-20!64;UBERON:0000955!4.71e-18!47;UBERON:0006238!4.71e-18!47;UBERON:0003056!7.02e-18!49;UBERON:0002616!1.43e-17!46;UBERON:0010371!4.22e-17!73;UBERON:0003080!5.57e-17!40;UBERON:0002780!1.98e-16!39;UBERON:0001890!1.98e-16!39;UBERON:0006240!1.98e-16!39;UBERON:0001017!5.19e-16!73;UBERON:0002020!6.10e-15!34;UBERON:0001016!1.19e-14!75;UBERON:0004121!4.97e-13!95;UBERON:0000924!4.97e-13!95;UBERON:0006601!4.97e-13!95;UBERON:0003528!8.15e-13!29;UBERON:0002791!8.15e-13!29;UBERON:0001893!8.15e-13!29;UBERON:0000956!1.47e-09!21;UBERON:0001869!1.47e-09!21;UBERON:0000203!1.47e-09!21;UBERON:0000025!1.54e-09!114;UBERON:0004111!2.88e-08!122;UBERON:0002021!4.21e-07!10;UBERON:0000411!4.21e-07!10;UBERON:0001950!4.21e-07!10;UBERON:0000468!4.54e-07!333;UBERON:0002619!6.08e-07!17
|ontology_enrichment_uberon=UBERON:0010314!8.87e-25!92;UBERON:0000073!8.70e-22!54;UBERON:0001049!2.12e-20!52;UBERON:0005068!2.12e-20!52;UBERON:0006241!2.12e-20!52;UBERON:0007135!2.12e-20!52;UBERON:0002346!4.36e-20!64;UBERON:0003075!4.36e-20!64;UBERON:0007284!4.36e-20!64;UBERON:0000955!4.71e-18!47;UBERON:0006238!4.71e-18!47;UBERON:0003056!7.02e-18!49;UBERON:0002616!1.43e-17!46;UBERON:0010371!4.22e-17!73;UBERON:0003080!5.57e-17!40;UBERON:0002780!1.98e-16!39;UBERON:0001890!1.98e-16!39;UBERON:0006240!1.98e-16!39;UBERON:0001017!5.19e-16!73;UBERON:0002020!6.10e-15!34;UBERON:0001016!1.19e-14!75;UBERON:0004121!4.97e-13!95;UBERON:0000924!4.97e-13!95;UBERON:0006601!4.97e-13!95;UBERON:0003528!8.15e-13!29;UBERON:0002791!8.15e-13!29;UBERON:0001893!8.15e-13!29;UBERON:0000956!1.47e-09!21;UBERON:0001869!1.47e-09!21;UBERON:0000203!1.47e-09!21;UBERON:0000025!1.54e-09!114;UBERON:0004111!2.88e-08!122;UBERON:0002021!4.21e-07!10;UBERON:0000411!4.21e-07!10;UBERON:0001950!4.21e-07!10;UBERON:0000468!4.54e-07!333;UBERON:0002619!6.08e-07!17
|tfbs_overrepresentation_for_novel_motifs=0.752782,0.193418,0.722405,0.801166,0.587814,0.81763,0.919454,1.17946,0.479531,0.66329,0.870507,0.906098,2.05331,0.933025,0.608226,0,1.14208,0.578045,0.448066,0.328717,0.679146,0.275782,0.932027,0.585919,0.731217,0.963352,0.437236,0.841386,0.64294,0.380786,0.825437,1.24901,0.575271,0.411696,0.608816,0.144706,0.563758,0.902078,0.536514,0.50014,0.582863,0.831295,0.261619,0.610669,0.922882,0.788421,1.05665,0.859154,0.663409,0.646474,1.12346,0.99279,0.971403,1.3966,1.41464,0.940919,0.657156,0.891887,0.425455,0.938668,1.22795,1.00308,0.494668,1.11142,0.953187,1.15459,1.55483,1.90983,1.22303,1.7608,0.700291,0.474956,1.41919,1.44925,0.416814,0.402065,0.411601,1.04436,1.20986,0.684144,0.476502,1.16055,1.00151,0.459035,1.32978,2.30787,0.195254,0.380977,1.06194,2.07346,1.62608,1.33496,1.26245,0.595071,0.531443,0.509215,1.17262,1.26539,1.05692,0.928366,0.563856,1.24872,1.37854,1.12409,1.12297,0.830796,1.18646,0.854628,0.689894,0.681267,0.744607,1.38039,0.685481,0.876299,1.63327,0.580657,0.609576,0.805461,1.14346,0.559153,1.45481,1.08896,0.965352,1.04338,1.68841,1.21376,0.928483,1.25534,1.55328,0.598722,1.36093,0.792832,1.52297,0.955954,1.65529,0.273451,0.762499,0.832891,1.60513,2.44352,2.04137,1.55966,0.978551,1.26,1.11604,0.831808,1.06002,2.40374,0.765221,0.589976,0.38417,0.721422,1.39822,0.516739,0.954936,1.48249,0.993889,0.622823,0.749933,0.762177,1.61484,1.32889,1.21423,1.75703,1.11251,0.94678,0.562367,0.904334,0.833542
}}
}}

Revision as of 23:11, 26 November 2012


Phase1 CAGE Peaks

 Short description
Mm9::chr7:53356097..53356140,-p1@Kcnj11
Mm9::chr7:53356146..53356191,-p3@Kcnj11
Mm9::chr7:53435299..53435402,-p1@Abcc8


Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data


GO IDGO nameFDR corrected p-value
GO:0015272ATP-activated inward rectifier potassium channel activity0.00536898044157125
GO:0005242inward rectifier potassium channel activity0.0375694788804962



Relative expression of the co-expression cluster over median <br>Analyst:





Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br>cell_data<br>uberon_data<br><br>


Cell Type
Ontology termp-valuen
CNS neuron (sensu Vertebrata)1.37e-1123
neuroblast (sensu Vertebrata)1.37e-1123

Uber Anatomy
Ontology termp-valuen
structure with developmental contribution from neural crest8.87e-2592
regional part of nervous system8.70e-2254
neural tube2.12e-2052
neural rod2.12e-2052
future spinal cord2.12e-2052
neural keel2.12e-2052
neurectoderm4.36e-2064
neural plate4.36e-2064
presumptive neural plate4.36e-2064
brain4.71e-1847
future brain4.71e-1847
pre-chordal neural plate7.02e-1849
regional part of brain1.43e-1746
ecto-epithelium4.22e-1773
anterior neural tube5.57e-1740
regional part of forebrain1.98e-1639
forebrain1.98e-1639
future forebrain1.98e-1639
central nervous system5.19e-1673
gray matter6.10e-1534
nervous system1.19e-1475
ectoderm-derived structure4.97e-1395
ectoderm4.97e-1395
presumptive ectoderm4.97e-1395
brain grey matter8.15e-1329
regional part of telencephalon8.15e-1329
telencephalon8.15e-1329
cerebral cortex1.47e-0921
cerebral hemisphere1.47e-0921
pallium1.47e-0921
tube1.54e-09114
anatomical conduit2.88e-08122
occipital lobe4.21e-0710
visual cortex4.21e-0710
neocortex4.21e-0710
multi-cellular organism4.54e-07333
regional part of cerebral cortex6.08e-0717


TFBS overrepresentation<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data


Novel motifs




JASPAR motifs


Motifs-log10(p-value)

{{{tfbs_overrepresentation_jaspar}}}